The present invention relates to methods for evaluating and predicting clinical outcomes in patients by measuring levels of sIP-10 protein expression as well as therapies using sIP-10 and its fragments.

 
Web www.patentalert.com

< Viral polymerase inhibitors

> Adjuvant compositions

> Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof
~ 00589